H2BC17

gene
On this page

Also known as H2B/nH2B.2

Summary

H2BC17 (H2B clustered histone 17, HGNC:4758) is a protein-coding gene on chromosome 6p22.1, encoding Histone H2B type 1-O (P23527). Core component of nucleosome.

Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2B family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the small histone gene cluster on chromosome 6p22-p21.3.

Source: NCBI Gene 8348 — RefSeq curated summary.

At a glance

  • GWAS associations: 18
  • Clinical variants (ClinVar): 13 total
  • MANE Select transcript: NM_003527

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4758
Approved symbolH2BC17
NameH2B clustered histone 17
Location6p22.1
Locus typegene with protein product
StatusApproved
AliasesH2B/n, H2B.2
Ensembl geneENSG00000274641
Ensembl biotypeprotein_coding
OMIM602808
Entrez8348

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000616182

RefSeq mRNA: 1 — MANE Select: NM_003527 NM_003527

CCDS: CCDS4640

Canonical transcript exons

ENST00000616182 — 1 exons

ExonStartEnd
ENSE000037177482789342527893891

Expression profiles

Bgee: expression breadth ubiquitous, 137 present calls, max score 95.61.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 317.5954 / max 9939.5629, expressed in 1703 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
66602316.36501702
666031.2303377

Top tissues by expression

241 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bone marrow cellCL:000209295.61gold quality
adrenal tissueUBERON:001830389.20gold quality
monocyteCL:000057680.99gold quality
leukocyteCL:000073879.82gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099177.65gold quality
granulocyteCL:000009470.76gold quality
colonic epitheliumUBERON:000039767.28gold quality
calcaneal tendonUBERON:000370164.83gold quality
ventricular zoneUBERON:000305364.14gold quality
bloodUBERON:000017862.67gold quality
bone marrowUBERON:000237159.51gold quality
tonsilUBERON:000237256.65gold quality
tendonUBERON:000004355.94gold quality
mucosa of transverse colonUBERON:000499154.30gold quality
right lungUBERON:000216751.76gold quality
spleenUBERON:000210650.88gold quality
rectumUBERON:000105250.86gold quality
lower esophagus mucosaUBERON:003583449.32gold quality
blood vessel layerUBERON:000479749.29gold quality
choroid plexus epitheliumUBERON:000391148.89gold quality
corpus callosumUBERON:000233647.78silver quality
periodontal ligamentUBERON:000826647.14gold quality
renal glomerulusUBERON:000007446.86gold quality
metanephric glomerulusUBERON:000473646.77gold quality
nephron tubuleUBERON:000123146.71gold quality
ganglionic eminenceUBERON:000402346.33gold quality
lymph nodeUBERON:000002946.14gold quality
lungUBERON:000204845.99gold quality
dorsal motor nucleus of vagus nerveUBERON:000287045.35gold quality
upper leg skinUBERON:000426245.33silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.23

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Paralogs (21): H2BW2 (ENSG00000101812), H2BW1 (ENSG00000123569), H2BC11 (ENSG00000124635), H2BC1 (ENSG00000146047), H2BC5 (ENSG00000158373), H2BC4 (ENSG00000180596), H2BC21 (ENSG00000184678), H2BC13 (ENSG00000185130), H2BC26 (ENSG00000196890), H2BC12 (ENSG00000197903), H2BC18 (ENSG00000203814), H2BC15 (ENSG00000233822), H2BC12L (ENSG00000234289), H2BC14 (ENSG00000273703), H2BC8 (ENSG00000273802), H2BC6 (ENSG00000274290), H2BC9 (ENSG00000275713), H2BC3 (ENSG00000276410), H2BC7 (ENSG00000277224), H2BC10 (ENSG00000278588), H2BK1 (ENSG00000285480)

Protein

Protein identifiers

Histone H2B type 1-OP23527 (reviewed: P23527)

Alternative names: H2B-clustered histone 17, Histone H2B.2, Histone H2B.n

All UniProt accessions (1): P23527

UniProt curated annotations — full annotation on UniProt →

Function. Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.

Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.

Subcellular location. Nucleus. Chromosome.

Post-translational modifications. Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is required for histone H3 ‘Lys-4’ (H3K4me) and ‘Lys-79’ (H3K79me) methylation and transcription activation at specific gene loci, such as HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121 (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 ‘Lys-4’ and ‘Lys-79’ methylation. It also functions cooperatively with the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub also acts as a regulator of mRNA splicing: deubiquitination by USP49 is required for efficient cotranscriptional splicing of a large set of exons. Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress promotes transcription. Phosphorylated on Ser-15 (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic chromatin condensation. Also phosphorylated on Ser-15 in response to DNA double strand breaks (DSBs), and in correlation with somatic hypermutation and immunoglobulin class-switch recombination. GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121. It fluctuates in response to extracellular glucose, and associates with transcribed genes. ADP-ribosylated by PARP1 or PARP2 on Ser-7 (H2BS6ADPr) in response to DNA damage. H2BS6ADPr promotes recruitment of CHD1L. Poly ADP-ribosylation on Glu-36 (H2BE35ADPr) by PARP1 regulates adipogenesis: it inhibits phosphorylation at Ser-37 (H2BS36ph), thereby blocking expression of pro-adipogenetic genes. Crotonylation (Kcr) is specifically present in male germ cells and marks testis-specific genes in post-meiotic cells, including X-linked genes that escape sex chromosome inactivation in haploid cells. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors. It is also associated with post-meiotically activated genes on autosomes. Lactylated in macrophages by EP300/P300 by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription.

Miscellaneous. The mouse orthologous protein does not seem to exist.

Similarity. Belongs to the histone H2B family.

RefSeq proteins (1): NP_003518* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000558Histone_H2BFamily
IPR007125H2A/H2B/H3Domain
IPR009072Histone-foldHomologous_superfamily
IPR055333HISTONE_H2B_siteConserved_site

Pfam: PF00125

UniProt features (106 total): modified residue 90, helix 4, cross-link 4, strand 2, initiator methionine 1, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1, sequence conflict 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
7WLPX-RAY DIFFRACTION2.29

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P23527-F188.040.68

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (94): 6, 6, 6, 7, 12, 12, 12, 12, 12, 12, 13, 13, 13, 15, 16, 16, 16, 16, 17, 17 …

Glycosylation sites (1): 113

Function

Pathways and Gene Ontology

Reactome pathways

58 pathways

IDPathway
R-HSA-110328Recognition and association of DNA glycosylase with site containing an affected pyrimidine
R-HSA-110329Cleavage of the damaged pyrimidine
R-HSA-110330Recognition and association of DNA glycosylase with site containing an affected purine
R-HSA-110331Cleavage of the damaged purine
R-HSA-1221632Meiotic synapsis
R-HSA-171306Packaging Of Telomere Ends
R-HSA-1912408Pre-NOTCH Transcription and Translation
R-HSA-201722Formation of the beta-catenin:TCF transactivating complex
R-HSA-212300PRC2 methylates histones and DNA
R-HSA-2299718Condensation of Prophase Chromosomes
R-HSA-2559580Oxidative Stress Induced Senescence
R-HSA-2559582Senescence-Associated Secretory Phenotype (SASP)
R-HSA-2559586DNA Damage/Telomere Stress Induced Senescence
R-HSA-3214815HDACs deacetylate histones
R-HSA-3214847HATs acetylate histones
R-HSA-427359SIRT1 negatively regulates rRNA expression
R-HSA-427389ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
R-HSA-427413NoRC negatively regulates rRNA expression
R-HSA-5250924B-WICH complex positively regulates rRNA expression
R-HSA-5334118DNA methylation
R-HSA-5578749Transcriptional regulation by small RNAs
R-HSA-5617472Activation of anterior HOX genes in hindbrain development during early embryogenesis
R-HSA-5625886Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
R-HSA-5689880Ub-specific processing proteases
R-HSA-5693565Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
R-HSA-5693571Nonhomologous End-Joining (NHEJ)
R-HSA-5693607Processing of DNA double-strand break ends
R-HSA-606279Deposition of new CENPA-containing nucleosomes at the centromere
R-HSA-68616Assembly of the ORC complex at the origin of replication
R-HSA-69473G2/M DNA damage checkpoint

MSigDB gene sets: 177 (showing top): REACTOME_MEIOTIC_RECOMBINATION, REACTOME_DNA_REPLICATION, REACTOME_SIGNALING_BY_NOTCH, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_MEIOTIC_SYNAPSIS, REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT, GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA, GOBP_HUMORAL_IMMUNE_RESPONSE, FISCHER_DREAM_TARGETS, GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION, REACTOME_DNA_REPAIR

GO Biological Process (1): nucleosome assembly (GO:0006334)

GO Molecular Function (4): DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982), protein binding (GO:0005515)

GO Cellular Component (5): nucleosome (GO:0000786), nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829), chromosome (GO:0005694)

Reactome top-level categories

Rollup of top-12 pathways:

CategoryPathways
Cellular Senescence3
Depyrimidination2
Depurination2
Epigenetic regulation of gene expression2
Chromatin modifying enzymes2
Negative epigenetic regulation of rRNA expression2
Positive epigenetic regulation of rRNA expression2
Meiosis1
Telomere Maintenance1
Pre-NOTCH Expression and Processing1
TCF dependent signaling in response to WNT1
Mitotic Prophase1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
chromatin2
cellular anatomical structure2
chromatin organization1
nucleosome organization1
protein-DNA complex assembly1
nucleic acid binding1
structural molecule activity1
protein dimerization activity1
binding1
protein-DNA complex1
intracellular membrane-bounded organelle1
nuclear lumen1
cytoplasm1
intracellular membraneless organelle1

Protein interactions and networks

STRING

2376 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
H2BC17H3C1P02295882
H2BC17PLGP00747867
H2BC17RNF20Q5VTR2843
H2BC17H3C14Q71DI3814
H2BC17H3-5Q6NXT2814
H2BC17H3-4Q16695814
H2BC17H3-3AP06351813
H2BC17H3-7Q5TEC6812
H2BC17RNF40O75150777
H2BC17H2AC19P20670761
H2BC17H2AC20Q16777760
H2BC17H4C16P02304746
H2BC17H4C7Q99525746
H2BC17DET1Q7L5Y6729
H2BC17USP22Q9UPT9727

IntAct

44 interactions, top by confidence:

ABTypeScore
H2AZ1ZNHIT1psi-mi:“MI:0914”(association)0.770
H2AXPPM1Gpsi-mi:“MI:0914”(association)0.730
XPCCETN3psi-mi:“MI:0914”(association)0.730
H2BC17PCDHB12psi-mi:“MI:0915”(physical association)0.560
ING4KAT7psi-mi:“MI:0914”(association)0.530
EPB41L5SETD1Apsi-mi:“MI:0914”(association)0.530
H2AC20PPM1Gpsi-mi:“MI:0914”(association)0.530
PRPF38AH2BC17psi-mi:“MI:0914”(association)0.510
ARRB1psi-mi:“MI:0914”(association)0.350
ARRB2psi-mi:“MI:0914”(association)0.350
Prdm16ESYT2psi-mi:“MI:0914”(association)0.350
EPB41L5AP3B1psi-mi:“MI:0914”(association)0.350
RPS6KA3BAG2psi-mi:“MI:0914”(association)0.350
AireNOP56psi-mi:“MI:0914”(association)0.350
Ppsi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
H1-7psi-mi:“MI:0914”(association)0.350
HNRNPCL1KPNA3psi-mi:“MI:0914”(association)0.350
ZNF346MPHOSPH10psi-mi:“MI:0914”(association)0.350
PRKRAMPHOSPH10psi-mi:“MI:0914”(association)0.350
ANP32EKPNA5psi-mi:“MI:0914”(association)0.350
H2AJWDR46psi-mi:“MI:0914”(association)0.350
CACUL1H2BC17psi-mi:“MI:0914”(association)0.350

BioGRID (369): HIST1H2BO (Affinity Capture-RNA), HIST1H2BO (Affinity Capture-RNA), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), PRPF38A (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS), HIST1H2BO (Affinity Capture-MS)

ESM2 similar proteins: A0A2R8Y619, O97484, P02284, P02285, P02286, P02287, P02288, P04255, P04913, P07794, P07795, P0C1H4, P16888, P16889, P16890, P19374, P21897, P23527, P27326, P30757, P33778, P35067, P35068, P35069, P48557, P57053, P62807, P62808, P70696, P83863, Q00715, Q00729, Q16778, Q27894, Q32L48, Q5QNW6, Q5R893, Q5RCP8, Q64475, Q64478

Diamond homologs: A0A2R8Y619, A2WKT1, A2WKT4, A2WWU2, A2XF66, A2YWI3, A3AGM4, O22582, O60814, O65819, P02281, P02283, P02284, P02285, P02286, P02287, P02288, P02289, P02290, P04255, P06145, P06899, P06900, P07794, P07795, P0C1H3, P0C1H4, P0C1H5, P10853, P10854, P14001, P16888, P16889, P16890, P17271, P19374, P21897, P23527, P27326, P27807

SIGNOR signaling

2 interactions.

AEffectBMechanism
SLBP“up-regulates quantity by expression”H2BC17“translation regulation”
“MSL acetyltransferase”“down-regulates activity”H2BC17monoubiquitination

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 49 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
heterochromatin formation533.6×1e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

13 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance12
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

38 predictions. Top by Δscore:

VariantEffectΔscore
6:27893596:TGCTG:Tdonor_gain0.7200
6:27893573:T:Gdonor_gain0.6800
6:27893637:GCCA:Gdonor_gain0.6700
6:27893597:GCTGA:Gdonor_gain0.6400
6:27893604:C:Tdonor_gain0.6100
6:27893569:A:Tdonor_gain0.5800
6:27893818:TCACC:Tdonor_gain0.5400
6:27893538:G:GTdonor_gain0.5300
6:27893592:A:ACacceptor_gain0.4900
6:27893840:G:GGdonor_gain0.4900
6:27893598:C:CGdonor_gain0.4800
6:27893839:A:AGdonor_gain0.4200
6:27893619:ACC:Aacceptor_gain0.4100
6:27893543:C:Tdonor_gain0.4000
6:27893591:CA:Cacceptor_gain0.3900
6:27893690:C:Tdonor_gain0.3900
6:27893825:G:GGdonor_gain0.3800
6:27893589:TACA:Tacceptor_gain0.3600
6:27893590:ACAA:Aacceptor_gain0.3600
6:27893824:A:AGdonor_gain0.3600
6:27893827:ACACC:Adonor_gain0.3600
6:27893843:A:AGdonor_gain0.3300
6:27893593:A:Gacceptor_gain0.3000
6:27893676:G:GCacceptor_gain0.2900
6:27893546:G:GTdonor_gain0.2800
6:27893585:C:CAacceptor_gain0.2700
6:27893599:T:Gdonor_gain0.2700
6:27893621:C:Aacceptor_gain0.2600
6:27893742:G:Tdonor_gain0.2600
6:27893634:A:ACacceptor_gain0.2500

AlphaMissense

813 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:27893599:T:CL46P1.000
6:27893605:A:CQ48P1.000
6:27893668:A:TD69V1.000
6:27893686:C:AA75D1.000
6:27893694:G:CA78P1.000
6:27893695:C:AA78D1.000
6:27893704:T:CL81P1.000
6:27893740:G:CR93T1.000
6:27893740:G:TR93M1.000
6:27893741:G:CR93S1.000
6:27893741:G:TR93S1.000
6:27893742:G:AE94K1.000
6:27893750:G:CQ96H1.000
6:27893750:G:TQ96H1.000
6:27893754:G:CA98P1.000
6:27893755:C:AA98D1.000
6:27893760:C:AR100S1.000
6:27893764:T:AL101Q1.000
6:27893764:T:CL101P1.000
6:27893775:G:AG105R1.000
6:27893775:G:CG105R1.000
6:27893775:G:TG105W1.000
6:27893776:G:AG105E1.000
6:27893776:G:TG105V1.000
6:27893778:G:AE106K1.000
6:27893782:T:AL107Q1.000
6:27893782:T:CL107P1.000
6:27893785:C:AA108D1.000
6:27893789:G:CK109N1.000
6:27893789:G:TK109N1.000

dbSNP variants (sampled 300 via entrez): RS1000031105 (6:27892110 C>T), RS1000538626 (6:27892660 G>A,C), RS1000653439 (6:27892473 AC>A), RS1001722973 (6:27891963 G>A), RS1001775135 (6:27892177 C>G), RS1001825482 (6:27893057 C>A,G,T), RS1003892930 (6:27894202 G>A,C), RS1006508969 (6:27891599 C>A,G), RS1007560035 (6:27892495 T>C), RS1008011219 (6:27893207 G>A,T), RS1008089069 (6:27892245 G>T), RS1009911597 (6:27893098 G>C,T), RS1010462329 (6:27892423 CT>C), RS1011592663 (6:27894288 G>A), RS1012639702 (6:27891700 C>A)

Disease associations

OMIM: gene MIM:602808 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

18 associations (top):

StudyTraitp-value
GCST004521_112Autism spectrum disorder or schizophrenia3.000000e-26
GCST004521_115Autism spectrum disorder or schizophrenia3.000000e-16
GCST004521_116Autism spectrum disorder or schizophrenia3.000000e-16
GCST004521_166Autism spectrum disorder or schizophrenia4.000000e-24
GCST004521_22Autism spectrum disorder or schizophrenia2.000000e-11
GCST004521_23Autism spectrum disorder or schizophrenia2.000000e-11
GCST004521_6Autism spectrum disorder or schizophrenia2.000000e-15
GCST004521_73Autism spectrum disorder or schizophrenia8.000000e-11
GCST004748_90Lung cancer2.000000e-10
GCST008921_6Asthma and major depressive disorder1.000000e-09
GCST010142_16Fish- and plant-related diet2.000000e-10
GCST010142_19Fish- and plant-related diet4.000000e-10
GCST010142_34Fish- and plant-related diet7.000000e-09
GCST010142_35Fish- and plant-related diet8.000000e-09
GCST010142_42Fish- and plant-related diet1.000000e-08
GCST010142_7Fish- and plant-related diet3.000000e-12
GCST010702_75Subcortical volume (MOSTest)3.000000e-11
GCST010703_272Brain morphology (MOSTest)7.000000e-16

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008111diet measurement
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases expression2
Dimethyl Sulfoxidedecreases expression, affects expression2
Doxorubicindecreases expression2
Particulate Matterincreases abundance, increases expression, decreases expression2
decabromobiphenyl etheraffects expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arseniteaffects cotreatment, decreases expression, increases abundance, increases expression1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
ferrous chlorideincreases expression1
coumarindecreases phosphorylation1
S-(1,2-dichlorovinyl)cysteineincreases expression, affects cotreatment1
licochalcone Bincreases expression1
jinfukangincreases expression1
incobotulinumtoxinAdecreases expression1
(+)-JQ1 compoundincreases expression1
Resveratroldecreases expression, affects cotreatment1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects cotreatment, decreases expression, increases abundance, increases expression1
Berberinedecreases expression1
Caffeineaffects phosphorylation1
Calcitrioldecreases expression, affects cotreatment1
Enzyme Inhibitorsincreases O-linked glycosylation, decreases activity1
Estradiolaffects expression1
Lipopolysaccharidesaffects cotreatment, increases expression1
Manganeseaffects cotreatment, decreases expression, increases abundance1
N-Nitrosopyrrolidinedecreases expression1
Oxygendecreases expression1
Plant Extractsaffects cotreatment, decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.